These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
597 related articles for article (PubMed ID: 18949355)
1. Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis. Yoneda K; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Fuke H; Yamamoto N; Masuya M; Horie R; Uchida K; Takei Y Int J Oncol; 2008 Nov; 33(5):929-36. PubMed ID: 18949355 [TBL] [Abstract][Full Text] [Related]
2. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis. Khvalevsky E; Rivkin L; Rachmilewitz J; Galun E; Giladi H J Cell Biochem; 2007 Apr; 100(5):1301-12. PubMed ID: 17243100 [TBL] [Abstract][Full Text] [Related]
3. The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma. Nojiri K; Sugimoto K; Shiraki K; Tameda M; Inagaki Y; Kusagawa S; Ogura S; Tanaka J; Yoneda M; Yamamoto N; Okano H; Takei Y; Ito M; Kasai C; Inoue H; Takase K Oncol Rep; 2013 May; 29(5):1737-43. PubMed ID: 23467704 [TBL] [Abstract][Full Text] [Related]
4. Functional cell surface expression of toll-like receptor 9 promotes cell proliferation and survival in human hepatocellular carcinomas. Tanaka J; Sugimoto K; Shiraki K; Tameda M; Kusagawa S; Nojiri K; Beppu T; Yoneda K; Yamamoto N; Uchida K; Kojima T; Takei Y Int J Oncol; 2010 Oct; 37(4):805-14. PubMed ID: 20811701 [TBL] [Abstract][Full Text] [Related]
5. Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway. Jiang Q; Wei H; Tian Z BMC Cancer; 2008 Jan; 8():12. PubMed ID: 18199340 [TBL] [Abstract][Full Text] [Related]
6. Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial cells. Matsukura S; Kokubu F; Kurokawa M; Kawaguchi M; Ieki K; Kuga H; Odaka M; Suzuki S; Watanabe S; Takeuchi H; Kasama T; Adachi M Clin Exp Allergy; 2006 Aug; 36(8):1049-62. PubMed ID: 16911361 [TBL] [Abstract][Full Text] [Related]
7. Double-stranded RNA-induced TLR3 activation inhibits angiogenesis and triggers apoptosis of human hepatocellular carcinoma cells. Guo Z; Chen L; Zhu Y; Zhang Y; He S; Qin J; Tang X; Zhou J; Wei Y Oncol Rep; 2012 Feb; 27(2):396-402. PubMed ID: 22075935 [TBL] [Abstract][Full Text] [Related]
8. TLR3 ligand induces NF-{kappa}B activation and various fates of multiple myeloma cells depending on IFN-{alpha} production. Chiron D; Pellat-Deceunynck C; Amiot M; Bataille R; Jego G J Immunol; 2009 Apr; 182(7):4471-8. PubMed ID: 19299748 [TBL] [Abstract][Full Text] [Related]
9. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Matsumoto M; Kikkawa S; Kohase M; Miyake K; Seya T Biochem Biophys Res Commun; 2002 May; 293(5):1364-9. PubMed ID: 12054664 [TBL] [Abstract][Full Text] [Related]
11. Signal regulatory protein alpha negatively regulates both TLR3 and cytoplasmic pathways in type I interferon induction. Dong LW; Kong XN; Yan HX; Yu LX; Chen L; Yang W; Liu Q; Huang DD; Wu MC; Wang HY Mol Immunol; 2008 Jun; 45(11):3025-35. PubMed ID: 18471880 [TBL] [Abstract][Full Text] [Related]
12. Expression of TNF-related apoptosis-inducing ligand in human hepatocellular carcinoma. Shiraki K; Yamanaka T; Inoue H; Kawakita T; Enokimura N; Okano H; Sugimoto K; Murata K; Nakano T Int J Oncol; 2005 May; 26(5):1273-81. PubMed ID: 15809718 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells. Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933 [TBL] [Abstract][Full Text] [Related]
14. Double-stranded RNA induces pancreatic beta-cell apoptosis by activation of the toll-like receptor 3 and interferon regulatory factor 3 pathways. Dogusan Z; García M; Flamez D; Alexopoulou L; Goldman M; Gysemans C; Mathieu C; Libert C; Eizirik DL; Rasschaert J Diabetes; 2008 May; 57(5):1236-45. PubMed ID: 18223009 [TBL] [Abstract][Full Text] [Related]